GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » 3-Year EPS without NRI Growth Rate

King International Investment (HKSE:00928) 3-Year EPS without NRI Growth Rate : 10.90% (As of Sep. 2023)


View and export this data going back to 2002. Start your Free Trial

What is King International Investment 3-Year EPS without NRI Growth Rate?

King International Investment's EPS without NRI for the six months ended in Sep. 2023 was HK$0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 10.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 33.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 27.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of King International Investment was 81.20% per year. The lowest was -14.60% per year. And the median was 25.50% per year.


Competitive Comparison of King International Investment's 3-Year EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, King International Investment's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


King International Investment's 3-Year EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where King International Investment's 3-Year EPS without NRI Growth Rate falls into.



King International Investment 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


King International Investment  (HKSE:00928) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


King International Investment 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of King International Investment's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


King International Investment (HKSE:00928) Business Description

Traded in Other Exchanges
N/A
Address
18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG
King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines